“The upgrade is based on Freeman’s solid financial performance in fiscal 2015 and through the first three quarters of 2016,” said S&P credit analyst Patrick Zagar.
The outlook is stable, reflecting S&P’s expectation that Freeman’s steady financial performance and volumes will continue.
More articles on healthcare finance:
Seniors foregoing health needs due to debt: 8 findings
RCM company to move 200 employees to new headquarters: 3 things to know
HHS rejects House Democrats’ initiative to curb high drug prices
